DMH1, a novel BMP small molecule inhibitor, increases cardiomyocyte progenitors and promotes cardiac differentiation in mouse embryonic stem cells.
The possibility of using cell-based therapeutics to treat cardiac failure has generated significant interest since the initial introduction of stem cell-based technologies. However, the methods to quickly and robustly direct stem cell differentiation towards cardiac cell types have been limited by a...
Main Authors: | Ada Ao, Jijun Hao, Corey R Hopkins, Charles C Hong |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3407188?pdf=render |
Similar Items
-
DMH1, a small molecule inhibitor of BMP type i receptors, suppresses growth and invasion of lung cancer.
by: Jijun Hao, et al.
Published: (2014-01-01) -
Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells.
by: Jijun Hao, et al.
Published: (2008-08-01) -
Functional cardiomyocytes derived from Isl1 cardiac progenitors via Bmp4 stimulation.
by: Esra Cagavi, et al.
Published: (2014-01-01) -
Comparison of Human Embryonic Stem Cell-Derived Cardiomyocytes, Cardiovascular Progenitors, and Bone Marrow Mononuclear Cells for Cardiac Repair
by: Sarah Fernandes, et al.
Published: (2015-11-01) -
Human embryonic stem cell derived mesenchymal progenitors express cardiac markers but do not form contractile cardiomyocytes.
by: Christophe M Raynaud, et al.
Published: (2013-01-01)